Existing indications repurposed to battle COVID-19
Post# of 72440
(Total Views: 463)
Posted On: 02/25/2021 2:44:24 PM
Existing indications repurposed to battle COVID-19 continue to come up short. It may well be that a first-in-class HDP, Brilacidin, is needed to defeat the newly emergent causative agent of COVID-19.
Emerging disease, meet emerging cure, Brilacidin. And we’d love to introduce Brilacidin to your friends.
Emerging disease, meet emerging cure, Brilacidin. And we’d love to introduce Brilacidin to your friends.
(5)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼